Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional an...
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
About this item
Full title
Author / Creator
the Oxford COVID Vaccine Trial Group , Oxford COVID Vaccine Trial Group , Barrett, Jordan R. , Belij-Rammerstorfer, Sandra , Dold, Christina , Ewer, Katie J. , Folegatti, Pedro M. , Gilbride, Ciaran , Halkerston, Rachel , Hill, Jennifer , Jenkin, Daniel , Stockdale, Lisa , Verheul, Marije K. , Aley, Parvinder K. , Angus, Brian , Bellamy, Duncan , Berrie, Eleanor , Bibi, Sagida , Bittaye, Mustapha , Carroll, Miles W. , Cavell, Breeze , Clutterbuck, Elizabeth A. , Edwards, Nick , Flaxman, Amy , Fuskova, Michelle , Gorringe, Andrew , Hallis, Bassam , Kerridge, Simon , Lawrie, Alison M. , Linder, Aline , Liu, Xinxue , Madhavan, Meera , Makinson, Rebecca , Mellors, Jack , Minassian, Angela , Moore, Maria , Mujadidi, Yama , Plested, Emma , Poulton, Ian , Ramasamy, Maheshi N. , Robinson, Hannah , Rollier, Christine S. , Song, Rinn , Snape, Matthew D. , Tarrant, Richard , Taylor, Stephen , Thomas, Kelly M. , Voysey, Merryn , Watson, Marion E. E. , Wright, Daniel , Douglas, Alexander D. , Green, Catherine M. , Hill, Adrian V. S. , Lambe, Teresa , Gilbert, Sarah and Pollard, Andrew J.
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
More than 190 vaccines are currently in development to prevent infection by the novel severe acute respiratory syndrome coronavirus 2. Animal studies suggest that while neutralizing antibodies against the viral spike protein may correlate with protection, additional antibody functions may also be important in preventing infection. Previously, we re...
Alternative Titles
Full title
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Authors, Artists and Contributors
Author / Creator
Oxford COVID Vaccine Trial Group
Barrett, Jordan R.
Belij-Rammerstorfer, Sandra
Dold, Christina
Ewer, Katie J.
Folegatti, Pedro M.
Gilbride, Ciaran
Halkerston, Rachel
Hill, Jennifer
Jenkin, Daniel
Stockdale, Lisa
Verheul, Marije K.
Aley, Parvinder K.
Angus, Brian
Bellamy, Duncan
Berrie, Eleanor
Bibi, Sagida
Bittaye, Mustapha
Carroll, Miles W.
Cavell, Breeze
Clutterbuck, Elizabeth A.
Edwards, Nick
Flaxman, Amy
Fuskova, Michelle
Gorringe, Andrew
Hallis, Bassam
Kerridge, Simon
Lawrie, Alison M.
Linder, Aline
Liu, Xinxue
Madhavan, Meera
Makinson, Rebecca
Mellors, Jack
Minassian, Angela
Moore, Maria
Mujadidi, Yama
Plested, Emma
Poulton, Ian
Ramasamy, Maheshi N.
Robinson, Hannah
Rollier, Christine S.
Song, Rinn
Snape, Matthew D.
Tarrant, Richard
Taylor, Stephen
Thomas, Kelly M.
Voysey, Merryn
Watson, Marion E. E.
Wright, Daniel
Douglas, Alexander D.
Green, Catherine M.
Hill, Adrian V. S.
Lambe, Teresa
Gilbert, Sarah
Pollard, Andrew J.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2471465297
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2471465297
Other Identifiers
ISSN
1078-8956,1546-170X
E-ISSN
1546-170X
DOI
10.1038/s41591-020-01179-4
